According to the latest report published by Data Bridge Market Research, the Scleroderma (Systemic Sclerosis) Treatment Market The global scleroderma (systemic sclerosis) treatment market size was valued at USD 532.49 million in 2024 and is projected to reach USD 1,209.57 million by 2032, with a CAGR of 10.80% during the forecast period of 2025 to 2032. This Scleroderma (Systemic...

Systemic scleroderma, also known as systemic sclerosis, is a rare autoimmune disorder characterized by excessive collagen production that leads to skin thickening and progressive damage to internal organs. Although there is currently no cure, significant advances in immunology and targeted therapies are transforming disease management. The growing demand within the scleroderma therapeutics...